Jump to section
To help create a world in which no lives are lost to treatable diseases, shaping healthier and safer future generations.
7% employee growth in 12 months
The health tracking market has attracted significant interest from millions of Americans, yet current solutions lack depth and personalization. Many existing software and hardware options rely on manual data entry or offer limited functionality through wearables, failing to address the intricate data of individual bodies. This creates a demand for more innovative and comprehensive health monitoring tools.
Q Bio is addressing the gap by developing advanced healthcare hardware and software that tracks and analyzes individual bodily data to create a 'digital twin'. This concept provides users with a real-time representation of their health, enabling them to monitor changes over time and gain valuable insights to inform their healthcare decisions.
The company sets itself apart from other health-tracking services with its combined focus on granular detail and long-term monitoring. By visualizing data as 'digital twins', Q Bio makes complex health metrics more relatable and understandable, enhancing user engagement and empowering individuals to take control of their health in a meaningful way.
Kirsty
Company Specialist at Welcome to the Jungle
Jul 2024
$27m
LATE VC
Mar 2020
$40m
SERIES B
This company has top investors
Dr. Garry Choy
(Co-Founder & Chief Medical Officer)Alongside Q Bio, they have also worked at UnitedHealth Group since 2019, initially as a Senior Vice President and Deputy Chief Medical Officer, they now served as the Chief Clinical Transformation Officer. They are also the co-founder of andros where they have served as the Chief Medical Officer and Com0pliance Officer since 2013.